GOLDENBERG GARY sold 12.5% of their position (13.49K shares) of VERRICA PHARMACEUTICALS INC. on the open market
Open‑market sale worth $35.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/28/2024ACC: 0001415889-24-022426
Director
Since Jun 2019
-13.49K
Net shares
Net seller
$35.2K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
13.49K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−9.89K
Price / share
$2.66
Trade value
$26.30K
% of position
9.2%
8/26/2024
107.75K→97.86K
Common Stock
Direct
Shares
−3.60K
Price / share
$2.46
Trade value
$8.86K
% of position
3.7%
8/27/2024
97.86K→94.26K
Total
Net shares
−13.49K
Net value
-$35.16K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/26/2024 | S · Sale | −9.89K | $2.66 | $26.30K | 9.2% | 107.75K | 97.86K |
| Common Stock Direct | 8/27/2024 | S · Sale | −3.60K | $2.46 | $8.86K | 3.7% | 97.86K | 94.26K |
| Total | −13.49K | -$35.16K | ||||||
Derivative Transactions0
No derivative transactions reported